Elevated blood hemoglobin on admission as an independent predictor of unfavorable outcomes in patients with aneurysmal subarachnoid hemorrhage
- PMID: 35366711
- DOI: 10.1007/s10143-022-01780-w
Elevated blood hemoglobin on admission as an independent predictor of unfavorable outcomes in patients with aneurysmal subarachnoid hemorrhage
Abstract
Hemoglobin (HGB), a potent spasmogen, may cause irreversible damage to the brain after aneurysm rupture. However, there is no clinical evidence to reveal the relationship between blood HGB concentrations on admission and the prognosis of patients with aneurysmal subarachnoid hemorrhage (aSAH). We retrospectively reviewed all aSAH patients admitted to our institution between January 2015 and December 2020. Functional outcome was assessed at 90 days after discharge using the modified Rankin scale (mRS). Independent risk factors associated with 90-day unfavorable outcomes were derived from a forward stepwise multivariate analysis. Receiver operating characteristic curve analysis was conducted to identify the best cutoff value of HGB to discriminate 90-day unfavorable outcomes. Then, patients were divided into two groups according to the cutoff value of HGB, and to account for imbalances in baseline characteristics, propensity score matching (PSM) was carried out to assess the impact of HGB on in-hospital complications. A total of 800 aSAH patients without anemia on admission were retrospectively enrolled in this study. Elevated blood HGB (OR = 1.02, 95% CI = 1.00-1.03, p = 0.018) on admission was identified as an independent risk factor associated with 90-day unfavorable outcomes, and the cutoff value was 149.5 g/L. After PSM, patients with an HGB > 149.5 g/L had a higher incidence of in-hospital delayed cerebral ischemia (DCI) (33.9% vs. 22.0%, p = 0.013) and deep vein thrombosis (DVT) (11.9% vs. 4.0%, p = 0.006). Patients with a blood HGB > 149.5 g/L on admission might develop more DCI and DVT during hospitalization, leading to 90-day unfavorable outcomes in aSAH patients. ClinicalTrials.gov Identifier: NCT04785976. 2021/03/05, retrospectively registered.
Keywords: Aneurysmal subarachnoid hemorrhage; Deep vein thrombosis; Delayed cerebral ischemia; Functional outcome; Hemoglobin.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Neutrophil-to-lymphocyte ratio as an independent predictor for unfavorable functional outcome in aneurysmal subarachnoid hemorrhage.J Neurosurg. 2019 Feb 1;132(2):400-407. doi: 10.3171/2018.9.JNS181975. Print 2020 Feb 1. J Neurosurg. 2019. PMID: 30717052
-
Elevated hemoglobin is associated with poor prognosis in Tibetans with poor-grade aneurysmal subarachnoid hemorrhage after clipping: A Retrospective Case-Control Study.Neurochirurgie. 2019 Dec;65(6):365-369. doi: 10.1016/j.neuchi.2019.06.005. Epub 2019 Jul 11. Neurochirurgie. 2019. PMID: 31301387
-
Serum Alkaline Phosphatase Level is Associated with Angiographic Vasospasm, Delayed Cerebral Ischemia-Caused Clinical Deterioration, and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.Neurocrit Care. 2019 Dec;31(3):466-475. doi: 10.1007/s12028-019-00714-7. Neurocrit Care. 2019. PMID: 31016639
-
Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.World Neurosurg. 2019 Nov;131:e65-e73. doi: 10.1016/j.wneu.2019.07.016. Epub 2019 Jul 8. World Neurosurg. 2019. PMID: 31295598
-
Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review.Neurol Ther. 2022 Jun;11(2):597-620. doi: 10.1007/s40120-022-00348-6. Epub 2022 Apr 20. Neurol Ther. 2022. PMID: 35441974 Free PMC article. Review.
Cited by
-
The association between hemoglobin concentration and clinical outcomes after aneurysmal subarachnoid hemorrhage: Insights from the LongTEAM registry.CNS Neurosci Ther. 2024 Apr;30(4):e14506. doi: 10.1111/cns.14506. Epub 2023 Oct 17. CNS Neurosci Ther. 2024. PMID: 37849416 Free PMC article.
-
Outcomes following poor-grade aneurysmal subarachnoid haemorrhage: a prospective observational study.Acta Neurochir (Wien). 2023 Dec;165(12):3651-3664. doi: 10.1007/s00701-023-05884-0. Epub 2023 Nov 16. Acta Neurochir (Wien). 2023. PMID: 37968366
-
Metabolomic and lipidomic pathways in aneurysmal subarachnoid hemorrhage.Neurotherapeutics. 2025 Jan;22(1):e00504. doi: 10.1016/j.neurot.2024.e00504. Epub 2024 Dec 19. Neurotherapeutics. 2025. PMID: 39701893 Free PMC article. Review.
References
-
- Ahn SH, Savarraj JP, Pervez M, Jones W, Park J, Jeon SB, Kwon SU, Chang TR, Lee K, Kim DH, Day AL, Choi HA (2018) The subarachnoid hemorrhage early brain edema score predicts delayed cerebral ischemia and clinical outcomes. Neurosurgery 83:137–145. https://doi.org/10.1093/neuros/nyx364 - DOI - PubMed
-
- Ayling OGS, Ibrahim GM, Alotaibi NM, Gooderham PA, Macdonald RL (2018) Anemia after aneurysmal subarachnoid hemorrhage is associated with poor outcome and death. Stroke 49:1859–1865. https://doi.org/10.1161/strokeaha.117.020260 - DOI - PubMed
-
- Azarov I, He X, Jeffers A, Basu S, Ucer B, Hantgan RR, Levy A, Kim-Shapiro DB (2008) Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide 18:296–302. https://doi.org/10.1016/j.niox.2008.02.006 - DOI - PubMed - PMC
-
- Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P, Stroke AHA, C, Council on Cardiovascular R, Intervention, Council on Cardiovascular N, Council on Cardiovascular S, Anesthesia, Council on Clinical C, (2012) Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 43:1711–1737. https://doi.org/10.1161/STR.0b013e3182587839 - DOI - PubMed
-
- Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC (2010) Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care 14:R23. https://doi.org/10.1186/cc8886 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- 2021YFC2501101/National Key Research and Development Program of China
- 2020YFC2004701/National Key Research and Development Program of China
- 82071296/National Natural Science Foundation of China
- 81671129/National Natural Science Foundation of China
- 81471210/National Natural Science Foundation of China
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous